NasdaqGM:PSNLLife Sciences
Personalis (PSNL) Reports Higher Sales And Wider Losses, Does The Stock Look Fully Valued?
How Personalis' latest earnings set the stage for investors
Personalis (PSNL) released Q2 2026 results on 4 August, with sales of US$22.36 million and a net loss of US$31.68 million. This mix of higher revenue and wider loss is central to how investors may reassess the stock.
For the first six months of 2026, Personalis reported sales of US$37.83 million and a net loss of US$61.72 million. Basic loss per share from continuing operations was US$0.59 for the period, including US$0.30 in Q2...